Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Given Average Recommendation of “Moderate Buy” by Analysts

Reckitt Benckiser Group plc (OTCMKTS:RBGLYGet Free Report) has been assigned an average recommendation of “Moderate Buy” from the seven ratings firms that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and three have assigned a strong buy recommendation to the company.

RBGLY has been the subject of a number of recent analyst reports. Barclays upgraded shares of Reckitt Benckiser Group to a “strong-buy” rating in a research report on Friday, October 4th. Sanford C. Bernstein lowered shares of Reckitt Benckiser Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 4th. Citigroup raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a research note on Tuesday, October 1st. UBS Group raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a research note on Wednesday, September 18th. Finally, JPMorgan Chase & Co. downgraded shares of Reckitt Benckiser Group from an “overweight” rating to a “neutral” rating in a research note on Thursday, August 29th.

View Our Latest Research Report on Reckitt Benckiser Group

Reckitt Benckiser Group Stock Performance

Shares of RBGLY stock opened at $12.26 on Tuesday. The company’s fifty day simple moving average is $12.32 and its two-hundred day simple moving average is $11.64. The company has a debt-to-equity ratio of 0.97, a current ratio of 0.69 and a quick ratio of 0.47. Reckitt Benckiser Group has a 1 year low of $10.24 and a 1 year high of $15.03.

About Reckitt Benckiser Group

(Get Free Report

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Featured Articles

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.